ValueAct to reduce stake in Gartner with stock offering

US— Gartner shareholder ValueAct Capital is to sell off around half of its shares in the company, reducing its stake from 17.5% to 8.7%.

Eight million shares are being sold, with Gartner itself committed to buying back half a million shares, provided the proposed offering goes ahead.

Shares in the offering are yet to be priced. The IT market research firm’s stock is currently trading at $37.50 a piece.

ValueAct’s chief investment officer Jeffrey Ubben (pictured) is a Gartner board director.

We hope you enjoyed this article.
Research Live is published by MRS.

The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.

Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.

For example, there's an archive of winning case studies from over a decade of MRS Awards.

Find out more about the benefits of joining MRS here.

0 Comments


Display name

Email

Join the discussion

Newsletter
Stay connected with the latest insights and trends...
Sign Up
Latest From MRS

Our latest training courses

Our new 2025 training programme is now launched as part of the development offered within the MRS Global Insight Academy

See all training

Specialist conferences

Our one-day conferences cover topics including CX and UX, Semiotics, B2B, Finance, AI and Leaders' Forums.

See all conferences

MRS reports on AI

MRS has published a three-part series on how generative AI is impacting the research sector, including synthetic respondents and challenges to adoption.

See the reports

Progress faster...
with MRS 
membership

Mentoring

CPD/recognition

Webinars

Codeline

Discounts